Have you been diagnosed with a brain tumour? Order your free information pack.

Brain tumour clinical trials we fund

The Brain Tumour Charity funds a number of clinical trials for designed to improve brain tumour treatment and care. Learn more about these trails using the resources on this page.

Clinical trials are research studies involving people. They test things like new drugs, treatment regiments, and lifestyle changes. 

There are two main types of clinical trials: interventional or observational. Interventional trials test a type of intervention like new drugs or a different treatment plan. Observational studies aim to find out what happens to people in different situations. 

Clinical trials are important because they thoroughly test new treatments to see if they’re safe and effective before they become widely available. 

The Brain Tumour Charity-funded clinical trials

The Brain Tumour Charity is committed to advancing research in the field of brain tumours and we fund a range of clinical trials. These include testing new therapies and treatments, as well as interventions to improve quality of life. 
Find out about the clinical trials we’re currently funding.

Professor Steve Clifford, who is lead on a brain tumour clinical trial funded by The Brain Tumour Charity

PNET5 trial: Medulloblastoma

This trial aims to improve the quality of survival by providing kinder and tailored treatments.

Professor Colin Watts, involved in brain tumour clinical trials

Tessa Jowell: BRAIN-MATRIX

This trial will enable doctors to treat brain tumours with drugs that are more targeted.

Dr Darren Hargrave, involved in brain tumour clinical trials

BIOMEDE

We’re funding the UK participation of BIOMEDE, an adaptive clinical trial for children with DMG (DIPG).

Dr David Jones

LOGGIC

The first trial that will evaluate the impact of low grade tumours and their treatment in children.

Dr Susan Picton

VINILO

Studying the potential of two drugs to treat young people with low grade gliomas.

Dr Paul Northcott

Medulloblastoma subtypes

Analysing over 1,200 samples, to determine if there are further tumour subtypes.

Professor Martin van den Bent

Anaplastic glioma

A grant to enable new analysis of an ongoing international clinical trial to impact on future trials.

A researcher involved in a quality of life trial

BT-LIFE

A quality of life trial that will evaluate the use of lifestyle and behavioural changes as a way to manage fatigue.

A researcher involved in using new image technology to visualise low grade gliomas

Mapping biomarkers

Using new imaging technology to visualise and measure protein build-up in low-grade diffuse gliomas.

A researcher developing a supported self-management programme to improve quality-of-life

Self-management Programme

Developing a supported self-management programme to improve quality-of-life